| Literature DB >> 35882879 |
Marwa H Gouda1, Noha A Elessawy2, Arafat Toghan3,4.
Abstract
Adsorption efficiency of Cefotaxime by novel nanocomposites beads composed of iota carrageenan (IC), sulfonated poly vinyl alcohol (SPVA) and nano sulfated zirconia (SZrO2) was evaluated in this study. SZrO2 was synthesized from solvent-free and easy calcination technique then embedded with 1-2.5 wt.% into the polymeric matrix. A batch adsorption experiment was carried out to investigate the effects of dosage, pH, beginning concentration, and time on Cefotaxime antibiotic adsorption. The ideal conditions to achieve complete removal are 88.97 mg L-1 initial cefotaxime concentration at time 3.58 h with 11.68 mg of beads composite with 2.5 wt.% of SZrO2. The pseudo second order kinetics model better illustrated the adsorption of cefotaxime on nanocomposite beads, and the maximum adsorption capacity are 659 mg g-1 for the composite with 2.5 wt.% of SZrO2. The mechanism of adsorption process depend mainly on the interactions between the different functional groups of SPVA, IC and SZrO2. The nanocomposites beads also exhibit excellent reproducibility after ten adsorption cycles. This type of nanocomposites beads can be easily separated from water without leaving any residue, verifying this novel nanocomposite beads has strong potential in water treatment for the antibiotic contaminant removal.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35882879 PMCID: PMC9325701 DOI: 10.1038/s41598-022-16473-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Kinetics and isotherms models of adsorption process.
| Model | Linear form | Eq. no | Plot | Parameters and constants |
|---|---|---|---|---|
| Pseudo-first-order kinetic | ln (qe − qt) = ln qe − k1t | (5) | ln(qe − qt) vs. t | k1 is the pseudo-first-order adsorption rate constant; qe is the amount of antibiotic adsorbed at saturation per gram of adsorbent (mg g−1), qt is the amount of antibiotic adsorbed at time t per gram of adsorbent (mg g−1) |
| Pseudo second-order kinetic | (6) | t/qt vs. t | k2 is adsorption rate constant of the pseudo-second-order | |
| Intraparticle diffusion kinetic | qt = ki t1/2 + C | (7) | qt vs. t1/2 | ki (mg g-1 min−1/2) is the intraparticle diffusion rate constant, which is the slope of the straight line of |
| Langmuir isotherm | (8) | (Ce/qe) vs. Ce | qe is the solid-phase concentration in equilibrium with the liquid-phase; concentration Ce is expressed in mole L−1; qm is the maximum monolayer adsorption capacity (mg g−1); and KL is an equilibrium constant (L mol−1) | |
| Freundlich isotherm | (9) | ln qe vs. ln Ce | plotting ln qe versus ln Ce gives a straight line with slope of 1/n, where n is a constant related to adsorption intensity and its magnitude shows an indication of the favorability of adsorption; the intercept is ln Kf where Kf is constant (function of energy of adsorption and temperature) |
Figure 1(a) FTIR spectra of SZrO2 and SPVA/IC/SO4ZrO2 composite beads, (b) XRD patterns of SZrO2 and SPVA/IC/ SZrO2 composite beads.
Figure 2SEM images for (a) SPVA/IC/ SZrO2-2.5 beads surface, (b) SPVA/IC/ SZrO2-2.5 inside, (c) TEM image for SZrO2 nanoparticles with the inset frequency distribution plot of SZrO2 nanoparticles size from TEM image, (d) EDX analysis for SZrO2.
Figure 3(a) TGA curves and (b) time dependent swelling response of SPVA/IC and SPVA/IC/SZrO2 nanocomposite beads.
Figure 4(a) Effect of solution's pH (0.01 g adsorbent beads, 50 mL of 100 mg L−1 Cefotaxime solution at 3 h adsorption time, and 25 °C temperature), (b) effect of SZrO2 concentration on Cefotaxime adsorption process.
Figure 5Adsorption kinetics of Cefotaxime onto composite beads at C0; 100 mg L−1, dose of adsorbent beads 0.2 mg mL−1, at 25 °C and pH 6.
Figure 6The perturbation plot.
Figure 7Response surface plots for removal efficiency (%) of Cefotaxime onto SPVA/IC/SZrO2-2.5 nanocomposite beads (a,c,e) 3D surface plots and (b,d,f) 2D surface plots.
Kinetic models’ parameters and determination coefficients for Cefotaxime adsorption onto SPVA/IC/SZrO2-2.5 nanocomposite beads.
| 50 | 100 | 150 | |
|---|---|---|---|
| qe,exp (mg g−1) | 246 | 475 | 659 |
| qe'cal (mg g−1) | 249.98 | 476.6 | 664.1 |
| k1(min−1) | 0.031 | 0.031 | 0.035 |
| R2 | 0.76 | 0.94 | 0.85 |
| qe,cal (mg g−1) | 245.8 | 476.1 | 658.7 |
| k2(min−1) | 0.0038 | 0.0019 | 0.0013 |
| R2 | 0.989 | 0.981 | 0.972 |
| ki | |||
| ki,1 | 15.16 | 31.13 | 64.48 |
| ki,2 | 12.88 | 18.24 | 17.25 |
| ki,3 | 1.89 | 0.48 | 2.4 |
| C | 45.69 | 56.84 | 64.48 |
| R2 | 0.92 | 0.87 | 0.94 |
Adsorption isotherm parameters for Cefotaxime adsorption onto SPVA/IC/SZrO2-2.5 nanocomposite beads at adsorbent dosage 0.2 mg mL−1.
| Temperature ºC | Ciprofloxacin adsorption onto FMFNs | ||
|---|---|---|---|
| 20 ºC | 30 ºC | 40 ºC | |
| qm (mg g−1) | 735 | 752 | 752 |
| kL(L mg−1) | 0.49 | 0.57 | 0.98 |
| R2 | 0.992 | 0.997 | 0.999 |
| RL | 0.1 | 0. 008 | 0.005 |
| KF (mg g−1) | 270 | 299 | 330 |
| 1/nF | 0.32 | 0.34 | 0.31 |
| R2 | 0.99 | 0.96 | 0.85 |
Figure 8Adsorption–desorption cycles.
A review of the performance of some nanocomposite adsorbent materials used to remove drug from water.
| Adsorbent nanomaterials | Adsorbate | Optimum adsorption condition | Adsorbate initial concentration (mg L−1) | Maximum adsorption capacity (mg g−1) | Reusability cycles/removal% after last cycle | References |
|---|---|---|---|---|---|---|
| Artich-Bch-NaOH | Metformin hydrochloride (MFH) | Acidic medium, 45 min | 10 | ~ 17 | 5 cycles, 78.5% | [ |
| NBent-NTiO2-Chit nanocomposite | Levofloxacin (LEVO) Ceftriaxone (CFT) | pH4, 10 min pH5, 10 min | 5 | ~ 43 ~ 36 | 3 cycles, 95% 3 cycles, 92.8% | [ |
| NFe3O4@Zn(GA)/Starch-Hydrogel | Fluvastatin (FLV) | pH2, 30 min | 40 | ~ 782 | 5 cycles, 700 mg g−1 | [ |
| V2O5@Ch/Cu-TMA nanobiosorbent | levofloxacin (LEVO) | pH3, 30 min | 10 | ~ 9 | 4 cycles, 84.35% | [ |
| Fe3O4–MoO3-AC | Ciprofloxacin (CPF) | pH7, 30 min | 10 | ~ 19 | 5 cycles, 90.5% | [ |
| SPVA/IC/SZrO2-2.5 nanocompoaite | Cefotaxime | pH6, 3 h | 100 | ~ 475 | 10 cycles, 91% | This work |